prolifagen.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot / ✔
BingBot / ✔
BaiduSpider / ✔
YandexBot / ✔ 
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php Sitemap:
Meta Tags
Title Prolifagen – Cardiac Regeneration Based on microRNA
Description Company Technology Team News Menu Company Technology Team News M. Alexander Shaw appointed CEO of Prolifagen Therapeutics Cardiac Regeneration Based on mi
Keywords N/A
Server Information
WebSite prolifagen faviconprolifagen.com
Host IP 104.196.67.245
Location United States
Related Websites
Site Rank
More to Explore
prolifagen.com Valuation
US$1,365
Last updated: 2023-05-03 00:32:16

prolifagen.com has Semrush global rank of 0. prolifagen.com has an estimated worth of US$ 1,365, based on its estimated Ads revenue. prolifagen.com receives approximately 157 unique visitors each day. Its web server is located in United States, with IP address 104.196.67.245. According to SiteAdvisor, prolifagen.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$1,365
Daily Ads Revenue US$1
Monthly Ads Revenue US$37
Yearly Ads Revenue US$453
Daily Unique Visitors 10
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
prolifagen.com. A 299 IP: 104.196.67.245
prolifagen.com. NS 900 NS Record: ns1.hover.com.
prolifagen.com. NS 900 NS Record: ns2.hover.com.
prolifagen.com. MX 900 MX Record: 10 mx.hover.com.cust.hostedemail.com.
HtmlToTextCheckTime:2023-05-03 00:32:16
Company Technology Team News Menu Company Technology Team News M. Alexander Shaw appointed CEO of Prolifagen Therapeutics Cardiac Regeneration Based on microRNA Technology Learn More OUR MISSION Preventing the Development of Heart Failure Our Background Prolifagen is a preclinical spin-out of University of Pennsylvania developing a medicine for cardiac regeneration based on microRNA technology. Our Team Our management team holds essential complementary skill sets in differing areas of domain expertise and bring decades of experience to this work. Our Work microRNA 302 drives proliferation of resident adult cardiac muscle cells in injured hearts, leading to reconstitution of functional heart muscle. We want to improve life after heart attack. More than 600,000 survivable heart attacks occur yearly in the US. That’s one heart attack every 40 seconds. 3 Million US people suffer from heart failure after a heart attack Twenty percent of those (linked to larger infarcts) will lead to Heart
HTTP Headers
HTTP/1.1 301 Moved Permanently
Server: nginx
Date: Mon, 25 Oct 2021 08:23:04 GMT
Content-Type: text/html
Content-Length: 162
Connection: keep-alive
Keep-Alive: timeout=20
Location: https://prolifagen.com/

HTTP/2 200 
server: nginx
date: Mon, 25 Oct 2021 08:23:05 GMT
content-type: text/html; charset=UTF-8
content-length: 38068
vary: Accept-Encoding
vary: Accept-Encoding
link: ; rel="https://api.w.org/"
link: ; rel="alternate"; type="application/json"
link: ; rel=shortlink
x-powered-by: WP Engine
x-cacheable: SHORT
vary: Accept-Encoding,Cookie
cache-control: max-age=600, must-revalidate
x-cache: HIT: 1
x-cache-group: normal
accept-ranges: bytes
prolifagen.com Whois Information
Domain Name: PROLIFAGEN.COM
Registry Domain ID: 2543174211_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.tucows.com
Registrar URL: http://www.tucows.com
Updated Date: 2020-07-01T20:43:45Z
Creation Date: 2020-07-01T20:43:44Z
Registry Expiry Date: 2030-07-01T20:43:44Z
Registrar: Tucows Domains Inc.
Registrar IANA ID: 69
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS1.HOVER.COM
Name Server: NS2.HOVER.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-13T12:24:29Z <<<

Copyright © 2022 WebZZ.US 0.0199